Autres langues Vertex Pharmaceuticals Incorporated

Actions

VRTX

US92532F1003

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 12/08/2026			Varia. 5j.	Varia. 1 janv.
525,73 ^USD	-0,74 %		+8,44 %	+15,96 %

12/08	Vertex dispose de multiples catalyseurs au sein de son portefeuille avec un profil risque-rendement favorable, selon RBC	MT
11/08	Vertex Pharmaceuticals Incorporated : Daiwa Securities réitère son opinion positive sur le titre	ZM

Autres langues

12/08	Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says
10/08	Vertex Shares Rise as Rival Sionna's Cystic-Fibrosis Trial Fails to Meet Endpoint
10/08	Sionna scraps genetic disorder drug program after trial setback; shares tank
05/08	Vertex Pharmaceuticals Incorporated : Quarterly Report for Quarter Ending JUNE 30, 2026 (Form 10-Q)
04/08	Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says
04/08	Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says
03/08	Vertex Pharmaceuticals Bumps Up Fiscal Year Outlook on Growth of Cystic Fibrosis Drugs
03/08	Vertex: Q2 Earnings Snapshot
03/08	Vertex Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance
03/08	(VRTX) Vertex Pharmaceuticals Now Expects 2026 Revenue Range $13.1B-$13.2B, vs. FactSet Est of $13.06B
03/08	Vertex raises annual revenue forecast on cystic fibrosis drugs strength
03/08	Earnings Flash (VRTX) Vertex Pharmaceuticals Incorporated Reports Q2 Revenue $3.33B, vs. FactSet Est of $3.23B
03/08	Earnings Flash (VRTX) Vertex Pharmaceuticals Incorporated Posts Q2 Adjusted EPS $4.73 per Share, vs. FactSet Est of $4.74
03/08	Vertex Reports Second Quarter 2026 Financial Results
03/08	Vertex Pharmaceuticals Incorporated Raises Earnings Guidance for Full Year 2026
03/08	Vertex Pharmaceuticals Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
03/08	Bedrijfskalender van 3 tot 7 augustus 2026
03/08	Falling Oil Boosts Wall Street Pre-Bell; Asia Mixed, Europe Up
03/08	Agenda de resultados empresariales del 3 al 7 de agosto de 2026
03/08	Calendario delle società: 3 - 7 agosto 2026
03/08	Unternehmenskalender vom 3. bis 7. August 2026
29/07	Abcellera Biologics Inc. Announces Collaboration with Vertex Pharmaceuticals Incorporated to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
24/07	Unternehmenskalender vom 27. bis 31. Juli 2026
21/07	Analystenempfehlungen: VAT, Belimo, Richemont, Salesforce, Goldman Sachs, Crowdstrike…
21/07	A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up